Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:38 PM
Ignite Modification Date:
2025-12-24 @ 3:38 PM
NCT ID:
NCT06168292
Eligibility Criteria:
Inclusion Criteria:
1. Patients 20 years of age or older, who voluntarily agree to participate in the study and sign the informed consent.
2. Patients with cytopathologically diagnosed inoperable extrahepatic cholangiocarcinoma
Exclusion Criteria:
1. Patients who refuse to sign the informed consent
2. Patients with metastatic cancer (stage IV) or malignant ascites
3. Patients with intrahepatic cholangiocarcinoma
4. Patients who are unable to undergo endoscopic procedures as determined by the investigator.
5. Patients with a life expectancy of 3 months or less
6. Patients with ID-RFA contraindications: pacemaker, pregnancy, uncorrected bleeding tendency (PT INR \> 1.5, platelets \< 50,000/mm3)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT06168292
Study Brief:
Protocol Section:
NCT06168292